Pulse Biosciences, Inc. Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
Pulse Biosciences, Inc. (PLSE) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable of 1.51 million shares as of 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Option, Exercise Price Range, Beginning of Period
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions · last filed 2019-03-14
- 2018-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 1.51M shares.
- 2017-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 831.69K shares.
- 2016-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 354.86K shares.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable |
|---|---|
| 2018-12-31 | 1.51M shares 10-K · filed 2019-03-14 |
| 2017-12-31 | 831.69K shares 10-K · filed 2018-03-16 |
| 2016-12-31 | 354.86K shares 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |